1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. C. R. Bard Acquires SenoRx

M&A Deal Summary

C. R. Bard Acquires SenoRx

On May 5, 2010, C. R. Bard acquired medical products company SenoRx for 213M USD

Acquisition Highlights
  • This is C. R. Bard’s 12th transaction in the Medical Products sector.
  • This is C. R. Bard’s 4th largest (disclosed) transaction.
  • This is C. R. Bard’s 15th transaction in the United States.
  • This is C. R. Bard’s 4th transaction in California.

M&A Deal Summary
Date 2010-05-05
Target SenoRx
Sector Medical Products
Buyer(s) C. R. Bard
Deal Type Add-on Acquisition
Deal Value 213M USD

Target

SenoRx

Irvine, California, United States
SenoRx develops, manufactures and sells minimally invasive medical devices used by breast care specialists for the diagnosis and treatment of breast cancer, including its EnCor® vacuum-assisted breast biopsy system and Contura® MLB catheter for delivering radiation to the tissue surrounding the lumpectomy cavity following surgery for breast cancer. SenoRx is based in Irvine, California.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

C. R. Bard

Murray Hill, New Jersey, United States
Category Company
Founded 1907
Sector Medical Products
Employees14,900
Revenue 3.7B USD (2016)
DESCRIPTION
Entrance to C. R. Bard's corporate headquarters in Murray Hill, New Jersey.
Entrance to C. R. Bard's corporate headquarters in Murray Hill, New Jersey.

C. R. Bard, Inc. is a multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of vascular, urology, oncology, and surgical specialties. C. R. Bard was formed in 1907 and is based in Murray Hill, New Jersey.

DEAL STATS #
Overall 16 of 23
Sector: Medical Products M&A 12 of 18
Type: Add-on Acquisition M&A Deals 15 of 22
State: California M&A 4 of 6
Country: United States M&A 15 of 22
Year: 2010 M&A 2 of 3
Size (of disclosed) 4 of 14
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-05-05 SensoRx

Irvine, California, United States

SenoRx markets the EnCor(R) stereotactic-guided and MRI-guided breast biopsy systems, the Gel Mark(R) line of breast tissue markers and the Contura(R) balloon catheter for the treatment of breast cancer. The Company is based in Irvine, California.

Buy $200M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-05-17 FlowCardia

Sunnyvale, California, United States

FlowCardia, Inc. is a medical device company which developed and marketed CROSSERTM, the safest and most effective solution for crossing chronic total occlusions in arteries.

Buy $80M
Mergr

Solution for

Product

Company

Legal